(Press-News.org) A commonly prescribed muscle relaxant may be an effective treatment for a rare but devastating form of diabetes, researchers at Washington University School of Medicine in St. Louis report.
The drug, dantrolene, prevents the destruction of insulin-producing beta cells both in animal models of Wolfram syndrome and in cell models derived from patients who have the illness.
Results are published Nov. 24 in the Proceedings of the National Academy of Sciences (PNAS) Online Early Edition.
Patients with Wolfram syndrome typically develop type 1 diabetes as very young children and need insulin injections several times each day. The syndrome also causes hearing loss, vision problems and difficulty with balance.
The researchers found that elevated levels of an enzyme called calpain 2 were the main cause of death in brain cells and insulin-producing cells. Dantrolene blocks that enzyme and also prevents brain cell death in animal and cell models of the disorder.
Because the drug is approved by the Food and Drug Administration (FDA), clinical trials in Wolfram patients could get underway relatively quickly, said senior investigator Fumihiko Urano, MD, PhD, the Samuel E. Schechter Professor of Medicine.
"We'd like to test the drug first in adult patients with Wolfram syndrome, and if we get positive results, we could extend the trial to children," he said.
Dantrolene often is prescribed to people with cerebral palsy or multiple sclerosis to treat muscle spasticity. If effective in patients with Wolfram syndrome, dantrolene also may be a viable treatment for patients with more common forms of diabetes. Calpain 2, which is involved in calcium metabolism, is overactive in cell models of those more common forms of diabetes.
Wolfram syndrome affects one in 500,000 people worldwide, and many patients die by age 40.
Urano and his team of researchers also studied the effects of dantrolene on stem cells from Wolfram syndrome patients and their close relatives, such as parents or siblings. Unlike adult stem cells collected from cord blood or stem cells developed from embryos, the stem cells in these studies were grown from skin cells. The researchers treated the stem cells with growth factors so they would differentiate into specific cell types, such as neurons and insulin-producing cells.
Cells that came from Wolfram patients produced high levels of calpain 2, which induced cell death. But when the researchers treated those cells with the drug, everything changed. Levels of the enzyme dropped, and the cells stopped dying.
"We also found that dantrolene was not toxic to cells grown from the skin samples donated by patients' relatives," Urano said. "The drug interfered with cell death in cells from Wolfram patients but did not harm cells that came from parents and siblings."
The researchers are hopeful that dantrolene also may be effective against type 1 and type 2 diabetes.
AUDIO:
Wolfram syndrome is a severe form of diabetes that affects only about one in 500,000 people, but researchers at Washington University School of Medicine in St. Louis believe finding ways...
Click here for more information.
"Wolfram is the most difficult form of diabetes because these patients have problems with blood sugar and so many other challenges," Urano said. "Calpain 2 also plays a role in type 1 and type 2 diabetes. Currently, we are studying the drug in animal and cell models of those types of diabetes to see if it also keeps insulin-producing cells from dying."
Having found that it also can prevent the death of brain cells and of insulin-secreting beta cells in Wolfram syndrome, Urano next wants to look more closely at how the drug affects other tissues, including the eye. Those studies will begin soon.
INFORMATION:
The research is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH), the Juvenile Diabetes Research Foundation, the American Diabetes Association, Team Alejandro, Team Ian, the Ellie White Foundation for Rare Genetic Disorders and the Jack and J.T. Snow Scientific Research Foundation. NIH grant numbers DK067493, P60 DK020579 and UL1 TR000448.
Lu S, Kanekura K, Hara T, Mahadevan J, Spears LD, Oslowski C, Martinez R, Yamazaki-Inoue M, Neilson A, Blanner P, Brown CM, Semenkovich CF, Marshall BA, Hershey T, Umezawa A, Greer PA, Urano F. A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome. PNAS Online Early Edition, Nov. 24, 2014 http://www.pnas.org/cgi/doi/10.1073/pnas.1421055111
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
(Edmonton) A team of researchers from the University of Alberta has discovered a new approach to fighting breast and thyroid cancers by targeting an enzyme they say is the culprit for the "vicious cycle" of tumour growth, spread and resistance to treatment.
A team led by University of Alberta biochemistry professor David Brindley found that inhibiting the activity of an enzyme called autotaxin decreases early tumour growth in the breast by up to 70 per cent. It also cuts the spread of the tumour to other parts of the body (metastasis) by a similar margin. Autotaxin is ...
High blood pressure and nonalcoholic fatty liver disease (NAFLD) are two emerging health problems related to the epidemic of childhood obesity. In a recent study, researchers at University of California, San Diego School of Medicine sought to determine the prevalence of high blood pressure in children with NAFLD, which places them at risk for premature cardiovascular disease.
The study, published in the November 24 edition of PLOS ONE, found that children with NAFLD are at substantial risk for high blood pressure, which is commonly undiagnosed.
"As a result of our ...
PRINCETON, N.J.--A team led by researchers from Princeton University, Michigan State University and the Indonesian Institute of Sciences have confirmed the discovery of a new bird species more than 15 years after the elusive animal was first seen on the Indonesian island of Sulawesi.
The newly named Sulawesi streaked flycatcher (Muscicapa sodhii), distinguished by its mottled throat and short wings, was found in the forested lowlands of Sulawesi where it had last been observed. The researchers report in PLOS ONE that the new species is markedly different from other flycatchers ...
November 24, 2014 - Differences in breast size have a significant mental health impact in adolescent girls, affecting self-esteem, emotional well-being, and social functioning, reports the December issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
More than just a "cosmetic issue," breast asymmetry can have negative psychological and emotional effects, according to the study by ASPS Member Surgeon Dr. Brian I. Labow and colleagues of Boston Children's Hospital. They suggest that early intervention ...
November 24, 2014 - For women considering breast reduction surgery, initial evaluation at a shared medical appointment (SMA) provides excellent patient satisfaction in a more efficient clinic visit, reports a study in the December issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Shared medical appointments have additional benefits, including "group learning, peer support, and a sense of solidarity and commonality" among women learning about breast reduction surgery, according to the study ...
Climate change could lengthen the growing season, make soil drier and decrease winter snowpack in the Lake Michigan Basin by the turn of the century, among other hydrological effects.
A new U.S. Geological Survey precipitation and runoff model shows that by 2100, maximum daily temperature in the Lake Michigan Basin could increase by as much as seven degrees Fahrenheit, and the minimum daily temperature by as much as eight degrees. A new USGS report published today summarizes the potential hydrological effects of these increases on the basin through 2099. The tools can ...
Lincoln, Neb., Nov. 24, 2104 -- The improvements in random access memory that have driven many advances of the digital age owe much to the innovative application of physics and chemistry at the atomic scale.
Accordingly, a team led by University of Nebraska-Lincoln researchers has employed a Nobel Prize-winning material and common household chemical to enhance the properties of a component primed for the next generation of high-speed, high-capacity RAM.
The team, which published its findings in the Nov. 24 edition of the journal Nature Communications, engineered and tested ...
Parents who spend their time playing with and talking to their five-month-old baby may wonder whether their child remembers any of it a day later.
Thanks to a new BYU study, we now know that they at least remember the good times.
The study, published in Infant Behavior and Development, shows that babies are more likely to remember something if there is a positive emotion, or affect, that accompanies it.
"People study memory in infants, they study discrimination in emotional affect, but we are the first ones to study how these emotions influence memory," said BYU psychology ...
Honeybee populations are clearly under stress--from the parasitic Varroa mite, insecticides, and a host of other factors--but it's been difficult to pinpoint any one of them as the root cause of devastating and unprecedented losses in honeybee hives. Researchers writing in the Cell Press journal Trends in Parasitology on November 24th say that the problem likely stems from a complex and poorly understood interplay of stresses and their impact on bee immunity and health. It's a situation they suspect might be improved through stress management and better honeybee nutrition.
As ...
MINNEAPOLIS, MN - November 24, 2014 - Nearly all individuals in their late 60s and early 70s -- including 100 percent of men -- now qualify for and should consider starting a statin medication to reduce their risk of cardiovascular disease, under the recently released cholesterol guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA).
That's according to a research letter published today in the 11/20/2014 (JAMA-IM) by Michael D. Miedema, MD, MPH, a research cardiologist at Minneapolis Heart Institute Foundation and cardiologist ...
